Privacy Statement

Your privacy is important to us. Dermira, Inc. ("Dermira"), a wholly-owned subsidiary of Eli Lilly and Company ("Lilly"), has established a privacy program designed to help us respect and protect your privacy rights. This Privacy Statement will let you know what Personal Information (PI) Dermira may collect, how we use it, how we protect it and your rights and choices with respect to your PI. This Privacy Statement applies to this website as well as websites, mobile applications and digital services ("websites") that link to or post it. It is incorporated into and made a part of our Terms of Use for this website, which include provisions that limit Dermira's liability.

PI We Collect and How We Use It

Depending on your interactions with Dermira, we may collect the following PI:

  • Name;
  • Full Date of Birth;
  • Gender;
  • Personal Contact Information (e.g., personal address, personal email address, personal phone/fax, personal web/internet address, family member names);
  • Online identifiers that correspond to your device(s) (e.g., personal IP [Internet Protocol] address, cookies, RFID, etc.);
  • Health Information;
  • Biographic Information;
  • Website Utilization and Social Media Use;
  • Commercial Information, (e.g., purchasing, consuming history or tendencies); and
  • Inferences Reflecting Preferences.

We collect PI from a number of sources, including:

  • Patients;
  • Health care professionals;
  • Consumers;
  • Customers;
  • Vendors, suppliers and contractors
  • Business partners; and
  • You.

We process/use PI for the following business or commercial purposes:

  • Research and development of our products;
  • Compliance with legal or regulatory obligations (e.g., adverse event reporting, exercising or defending legal claims, financial disclosure reporting);
  • Business and market research;
  • Market research for our products and services;
  • Study recruitment;
  • Marketing and sales of our products;
  • Communicating information about our products, responding to requests and registration for services;
  • Providing patient assistance;
  • Finance and tax activities;
  • Statistical analytics;
  • Contracting and business planning activities; and
  • Administration of other legal and business processes that are in Dermira's legitimate interest, inclusive of company record retention, safeguarding our physical and electronic workplace and website management.

Dermira may share your PI with:

  • Dermira and Lilly employees and affiliates;
  • Health care professionals;
  • Vendors, suppliers and contractors;
  • Business partners; and
  • Government officials (e.g., law enforcement authorities, the courts, regulatory authorities).

Where permitted by law, Dermira may also enhance or merge information, including PI, with information obtained from third parties for the same purposes shared above. PI may also be used for profiling for the same purposes shared above. You may object to profiling via automated-decision making by contacting us using the information in the "How to Contact Us" section below.

You do not have to share your PI with us, but if you choose not to share your PI, we may not be able to provide you with certain information, products or services.

In the ordinary course of business, Dermira sometimes collects Social Security numbers to fulfill legal or regulatory obligations or for other administrative purposes. We respect the confidentiality of Social Security numbers, and we avoid the unnecessary collection of them, limit access to them and disclose them only (i) according to Dermira's internal policies and procedures, (ii) with those third parties who are legally or contractually obligated to protect them, and (iii) as required or permitted by law.

Through this website, Dermira may:

  • Collect your Name and Personal Contact Information if you opt-in to receive communications (such as requests for information, responses to inquiries, newsletters, etc.). Dermira may also use this information to verify your relationship with Dermira and take other actions to respond to your request.
  • Collect online identifiers that correspond to your device(s) that do not directly identify you to improve, manage and secure our websites, network systems and other assets; verify your relationship with us; understand your interests and preferences; take other actions that may be necessary to respond to your request.
  • Analyze your website usage, including the date and time of your website session, geographic location, how you have navigated the website and other information collected through our web beacons, cookies, third-party and digital advertising, Google Analytics® and social media plug-ins. This information is collected for our legitimate business purposes.

Web beacons: A web beacon (also known as an "action tag" or "clear GIF technology") is a tiny graphic on a web page or in an email message designed to track pages viewed or messages opened, and allows the collection of web log information. Web log information is gathered by the computer that hosts our website (called a "webserver") when you visit one of our sites. We may use web beacons to help determine which email messages sent by us were opened and whether a message was acted upon. Web beacons also help Dermira analyze the effectiveness of websites by measuring the number of visitors to a site or how many visitors clicked on key elements of a site.

Cookies: A cookie is a small data file that a website can place on your computer's hard drive where your internet browser files are kept. A cookie saves you the trouble of reentering certain information in some registration areas because cookies can be used to enable a site to "remember" information a visitor has previously inputted. A cookie also helps deliver content and features likely to be of interest to you, based on your previous activities on our site, and track how sections of the website are used. Cookies can be placed on your computer both by us and by third parties with whom we have a relationship, such as web analytic services and advertising network services. In addition, cookies may be used to remarket employment opportunities to you in the United States. With most internet browsers or other software, you can change your browser settings to erase cookies from your computer hard drive, block all cookies or receive a warning before a cookie is stored. Please check your browser instructions to learn more about these functions. If you reject cookies, the functionality of the site may be limited, and you may not be able to take advantage of many of the site's features.

  • Choices about Cookies: If you would like to opt-out of, or manage, cookies used for targeted advertising, you may do so by following the options provided by the Network Advertising Initiative and the Digital Advertising Alliance. Ads displayed to you using this technology will usually have an AdChoices logo in the corner, which you can also click on to begin the same opt-out process. Additionally, if you receive ads on a social media site, you can check that site's privacy statement and terms of use to determine how to stop seeing such ads. The European Interactive Digital Advertising Alliance keeps a website where people can opt-out of receiving interest-based advertising from some or all of the network advertising companies participating in the program. You can find information about the EDAA here.
  • Do Not Track: There are different ways you can prevent tracking of your online activity. One of them is setting a preference in your browser that alerts websites you visit that you do not want them to collect certain information about you. This is referred to as a Do-Not-Track ("DNT") signal. Please note that currently, our websites and web-based resources do not respond to these signals from web browsers. At this time, there is no universally accepted standard for what a company should do when a DNT signal is detected.

Third-Party and Digital Advertising: We may partner with third-party advertising networks to manage our advertising on other sites. Our ad network partners may place cookies and web beacons and similar digital markers on your browser when you visit our websites to collect information about your activities over time on this and third-party sites, apps and other online services, to provide you targeted advertising based upon your interests. We may also share PI about you with third parties to have those third parties, on our behalf, directly serve advertising to you on their websites.

Google Analytics: Google Analytics may be used to help make our website work better and to help us understand what parts of the site are being utilized. Google Analytics uses technical tools such as first-party cookies and JavaScript® code to collect information about visitors. The Google Analytics service tracks visitors to the site who have JavaScript enabled. Google Analytics anonymously tracks how visitors interact with a website, including where they came from and what they did on a site. Google Analytics collects the information set forth above from users. This information is used to administer and update the website, and we will assess whether the visitors to the site match the expected site demographics and determine how key audiences are navigating the content. First-party cookies (such as the Google Analytics cookie) and third-party cookies (such as the DoubleClick cookie) will be used to report how your ad impressions, other uses of ad services and interactions with these ad impressions and ad services are related to visits to this site.

  • Opt-Out Provision: Google Analytics offers an opt-out provision for website visitors who do not want their data to be collected. You can receive more information about this option here.
  • Google's Use of Data: Google and its wholly-owned subsidiaries may retain and use, subject to the terms of its Privacy Policy (located here, or at another such URL that Google may provide from time to time), information collected in your use of the Google Analytics Information Disclosures and Sharing.

Social Media Plug-ins: Our websites may use social media plug-ins to enable you to share information with others easily. When you visit our websites, the operator of the social media plug-in that is on our website can place a cookie on your computer that lets that operator recognize individuals on their website who have previously visited our sites. Social media plug-ins may allow social media websites to receive directly identifiable information about you that shows you have visited our website. The social media plug-in may collect this information for visitors, whether or not they specifically interact with the plug-in on our website. Social media plug-ins also allow the social media website to share information about your activities on our website with other users of their social media website. Dermira does not control any of the content from social media plug-ins. For more information about social plug-ins from social media websites, you should refer to those sites' privacy and data sharing statements.

Children’s Information
This website is not intended for or designed for individuals under the age of 18. We do not knowingly collect PI from any person under the age of 18.
Reasons We Share PI

We may share your PI with third parties in connection with work that they do for or with Dermira, for purposes consistent with those listed above. These third parties must agree to protect the PI and to use it only as directed by Dermira.

We may also be required to disclose your information in response to lawful information requests for PI by law enforcement authorities, the courts or regulatory authorities, including complying with national security or law enforcement requests.

In the event that Dermira may decide to reorganize or divest part or all of its business, including its information databases, through a sale, divestiture, merger, acquisition or other means of transfer, then PI may be shared with, sold, transferred, rented, licensed or otherwise provided or made available by Dermira to third parties in connection with the contemplated transaction (without your consent or any further notice to you). In such circumstances, Dermira will seek written assurances that the PI will be protected appropriately.

Where We Transfer and Work With PI

This website is owned and operated by Dermira in the United States. However, any information collected on this website may be transferred to other third parties worldwide. Some of these third parties may be located in countries that do not require the same level of data protection as the country where you reside. Nevertheless, all third parties are required to treat PI in a manner consistent with applicable law. As explained in the "Reasons We Share PI" section above, PI may be shared as appropriate with third parties that process information on behalf of, or with, Dermira. If we disclose PI to a third party, Dermira ensures that the third party has contractual provisions that require an appropriate level of security and confidentiality safeguards as provided by Dermira. By using this website, you consent to the collection, storage and processing of your PI in the United States and in any country to which we may transfer your information in the course of our business operations.

If you want to view your PI that Dermira processes and request its correction, amendment or deletion, please contact us using the information in the "How to Contact Us" section below.

To obtain additional information regarding the basis for transfers and safeguards that Dermira has in place for cross-border transfers of PI, please contact us at privacy@Dermira.com.

How Long We Keep PI

PI will be saved for a period of time needed to fulfill legitimate business purposes.

How We Secure PI

We provide reasonable physical, technical and procedural safeguards to protect PI we work with and maintain. We limit access to PI to authorized employees and third parties who need access to carry out their assigned roles and responsibilities on behalf of Dermira. Although we strive to protect the PI that we work with and maintain, no security system can prevent all potential security breaches.

Your Rights and Choices

Upon verification of your identity and as legally applicable, you have the right to request information from us on how your PI is being used and with whom it is being shared. Information about our process to verify your identity can be found here. You also have the right and choice to request to see and receive a copy of the PI that we have about you, request that we correct, restrict the processing of, and/or erase/delete your PI, or in France, set expectations for the handling of your data after your death.

In limited circumstances, you may have the right to have your information transmitted to another entity or person in a machine-readable format.

There may be exceptions that apply to your request.

To exercise your rights, you or your authorized representative may submit a request to privacy@Dermira.com or by contacting us using one of the methods listed under the "How to Contact Us" section. You can find information regarding our responses to US requests regarding personal information here. Instructions on appointing an authorized representative to submit US requests for personal information on your behalf can be found here.

California Privacy Rights

California Civil Code Section 1798.83 entitles California residents who have an established business relationship with Dermira the right to request information regarding Dermira's disclosure of certain PI to third parties for their direct marketing purposes. To request such information, you may contact us using the information in the "How to Contact Us" section below.

California Consumer Privacy Act (CCPA) entitles California residents to certain rights with regard to their PI. Those rights have been incorporated into this privacy statement.

We do not sell personal information.

How to Contact Us

You may make any of the above requests by using the contact information below:

Dermira, Inc.
275 Middlefield Road, Suite 150
Menlo Park, California 94025
toll-free (800)783-0062
privacy@Dermira.com

You may also contact us at the above if you have questions about this Privacy Statement.

How to Submit a Complaint

If you wish to raise a complaint on how we have handled your PI, you can contact our Data Protection Officer at privacy@Dermira.com, who will investigate the matter.

If you are not satisfied with our response or believe we are not processing your PI in accordance with the law, you can register a complaint with relevant regulatory authority (e.g., Data Protection Authority or Attorney General).

Links to Third-Party Websites

As a convenience to our visitors, this website may contain links to other sites owned and operated by third parties that we believe may offer useful information. The policies and procedures we describe here do not apply to those sites. We are not responsible for the collection or use of PI at any third-party sites. Therefore, we disclaim any liability for any third party's use of PI obtained by using the third-party website. We suggest contacting those sites directly for information on their privacy, security, data collection and distribution policies.

Changes to Our Privacy Practices

We may update this Privacy Statement from time to time. When we do update it, for your convenience, we will make the updated statement available on this page. We will always handle your PI in accordance with the Privacy Statement in effect at the time it was collected unless we provide you with the new notice and/or obtain your consent, as appropriate.

Last Updated: June 16, 2020.

Other company and product names are trademarks of their respective owners.

INDICATION AND IMPORTANT
SAFETY INFORMATION
INDICATION

QBREXZA is an anticholinergic indicated for topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

IMPORTANT SAFETY INFORMATION

Contraindications: QBREXZA is contraindicated in patients with medical conditions that can be exacerbated by the anticholinergic effect of QBREXZA (e.g., glaucoma, paralytic ileus, unstable cardiovascular status in acute hemorrhage, severe ulcerative colitis, toxic megacolon complicating ulcerative colitis, myasthenia gravis, Sjogren’s syndrome).

INDICATION

QBREXZA is an anticholinergic indicated for topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

IMPORTANT SAFETY INFORMATION

Contraindications: QBREXZA is contraindicated in patients with medical conditions that can be exacerbated by the anticholinergic effect of QBREXZA (e.g., glaucoma, paralytic ileus, unstable cardiovascular status in acute hemorrhage, severe ulcerative colitis, toxic megacolon complicating ulcerative colitis, myasthenia gravis, Sjogren’s syndrome).

WARNINGS AND PRECAUTIONS

Worsening of Urinary Retention: QBREXZA should be used with caution in patients with a history or presence of documented urinary retention. Prescribers and patients should be alert for signs and symptoms of urinary retention (e.g., difficulty passing urine, distended bladder), especially in patients with prostatic hypertrophy or bladder-neck obstruction. Instruct patients to discontinue use immediately and consult a physician should any of these signs or symptoms develop. Patients with a history of urinary retention were not included in the clinical studies.

Control of Body Temperature: In the presence of high ambient temperature, heat illness (hyperpyrexia and heat stroke due to decreased sweating) can occur with the use of anticholinergic drugs such as QBREXZA. Advise patients using QBREXZA to watch for generalized lack of sweating when in hot or very warm environmental temperatures and to avoid use if not sweating under these conditions.

Operating Machinery or an Automobile: Transient blurred vision may occur with use of QBREXZA. If blurred vision occurs, the patient should discontinue use until symptoms resolve. Patients should be warned not to engage in activities that require clear vision such as operating a motor vehicle or other machinery, or performing hazardous work until the symptoms have resolved.

ADVERSE REACTIONS

The most common adverse reactions seen in ≥2% of subjects treated with QBREXZA were dry mouth (24.2%), mydriasis (6.8%), oropharyngeal pain (5.7%), headache (5.0%), urinary hesitation (3.5%), vision blurred (3.5%), nasal dryness (2.6%), dry throat (2.6%), dry eye (2.4%), dry skin (2.2%) and constipation (2.0%). Local skin reactions, including erythema (17.0%), burning/stinging (14.1%) and pruritus (8.1%) were also common.

DRUG INTERACTIONS

Anticholinergics: Coadministration of QBREXZA with anticholinergic medications may result in additive interaction leading to an increase in anticholinergic adverse effects. Avoid coadministration of QBREXZA with other anticholinergic-containing drugs.

INSTRUCTIONS FOR ADMINISTERING QBREXZA

Instruct patients to use one cloth to apply QBREXZA to both axillae by wiping the cloth across one underarm, ONE TIME. Using the same cloth, apply the medication to the other underarm, ONE TIME. Inform patients that QBREXZA can cause temporary dilation of the pupils and blurred vision if it comes in contact with the eyes.

Instruct patients to wash their hands with soap and water immediately after discarding the used cloth.

USE IN SPECIFIC POPULATIONS

Pregnancy: There are no available data on QBREXZA use in pregnant women to inform a drug-associated risk for adverse developmental outcomes.

Lactation: There are no data on the presence of glycopyrrolate or its metabolites in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for QBREXZA and any potential adverse effects on the breastfed infant from QBREXZA or from the underlying maternal condition.

Renal Impairment: The elimination of glycopyrronium is severely impaired in patients with renal failure.